logo

Mallinckrodt Plc (MNK)



Trade MNK now with
  Date
  Headline
6/18/2018 6:33:55 AM Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel Studies
5/8/2018 6:05:41 AM Mallinckrodt Posts Q1 Net Loss Of $18 Mln Or $0.21/share
5/3/2018 6:51:38 PM Mallinckrodt Says FDA Committee Recommend That Risk-benefit Profile Of Stannsoporfin Does Not Support Approval
5/2/2018 2:51:27 PM B. Riley FBR Starts Mallinckrodt plc (MNK) At Neutral With $15 Price Target
4/4/2018 6:26:33 AM Mallinckrodt Nominates Two New Members, Paul Carter And Anne Whitaker, To Its Board
4/4/2018 6:21:18 AM Mallinckrodt: Angus Russell To Succeed Melvin Booth As Chairman Of Board In May 2018
3/19/2018 7:49:31 AM Mallinckrodt Closes Sale Of RECOTHROM And PREVELEAK To Baxter
2/27/2018 6:07:38 AM Mallinckrodt Q4 GAAP EPS From Cont Ops $17.40 Vs Loss $1.67 Last Year
2/23/2018 6:56:51 AM Mallinckrodt Receives FDA Acceptance Of Stannsoporf In New Drug Application Filing
2/14/2018 6:31:46 AM Mallinckrodt Enrolls First Patient In Phase 1 Study Of ExpressGraft C9T1 Skin Tissue
2/13/2018 9:03:06 AM Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals
2/6/2018 5:54:23 PM Boyd Gaming Set To Join S&P MidCap 400; Ring Energy, James River Group And EVERTEC To Join S&P SmallCap 600
2/1/2018 9:06:35 AM Mallinckrodt Appoints Mark Casey As General Counsel